Vet Med - Czech, 2012, 57(11):575-582 | DOI: 10.17221/6464-VETMED

Susceptibility of Mycoplasma bovis field isolates to antimicrobial agents

J. Siugzdaite, A. Gabinaitiene, S. Kerziene
Lithuanian University of Health Science, Veterinary Academy, Kaunas, Lithuania

The purpose of this study was to determine the antibacterial susceptibility of field isolates of Mycoplasma bovis originating from the upper respiratory tract of cattle of different ages. Bacteriological examination of 90 nasal swabs collected from calves at three months of age identified M. bovis in 31 (34.44%) samples. Seventeen (18.88%) of these animals still housed M. bovis in their nasal cavity at nine months and five animals (5.55%) still at seventeen months of age. M. bovis were confirmed by biochemical and antigenic methods. To confirm that these belonged to the M. bovis species isolated mycoplasmas were tested using the PCR method. Fifteen field strains of M. bovis isolated from the same cattle at three, nine and seventeen months (five strains from each age group) were selected for antibacterial susceptibility testing against six groups of antimicrobial agents using an agar dilution method. The MIC90 ranges established for tylosin, tulathromycin, enrofloxacin, florfenicol and lincomycin were 0.39-0.78 µg/ml, 0.50-1.00 µg/ml, 0.78-1.56 µg/ml, 3.12 µg/ml and 0.39-0.78 µg/ml, respectively. The range of MIC90 for oxytetracycline was from 50 to 100 µg/ml. Preliminary examination of the antimicrobial susceptibility of field strains of M. bovis did not reveal significant differences between different age groups of cattle. After evaluation of the MIC90 data with the SPSS 13.0 statistical package it was found that M. bovis isolates from animals at three, nine and seventeen months were similarly susceptible to tylosin and tulathromycin. Statistically significant differences in susceptibility of M. bovis isolated from cattle of different ages were found to florfenicol compared with tulathromycin (P < 0.01), lincomycin (P < 0.01) and enrofloxacin (P < 0.05). The susceptibility of all M. bovis isolates to oxytetracycline and penicillin G significantly differed from the sensitivity to all other antimicrobial agents used in the present study (P < 0.05). The in vitro susceptibility test showed that field isolates of M. bovis isolated from cattle of different ages were similarly sensitive to tylosin, tulathromycin, lincomycin and enrofloxacin. It was also determined that the field strains are resistant to oxytetracycline.

Keywords: Mycoplasma bovis; cattle; minimal inhibitory concentration

Published: November 30, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Siugzdaite J, Gabinaitiene A, Kerziene S. Susceptibility of Mycoplasma bovis field isolates to antimicrobial agents. Vet Med - Czech. 2012;57(11):575-582. doi: 10.17221/6464-VETMED.
Download citation

References

  1. Aluotto BB, Wittler RG, Williams CO, Faber JE (1970): Standardized bacteriologic techniques for the characterization of Mycoplasma species. International Journal of Systematic Bacteriology 20, 35-58. Go to original source...
  2. Arcangioli MA, Duet A, Meyer G, Dernburg A, Bezille P, Poumarat F, Le Grand D (2008): The role of Mycoplasma bovis in bovine respiratory disease outbreaks in veal calf feedlots. Veterinary Journal 177, 89-93. Go to original source... Go to PubMed...
  3. Aylingas RD, Baker SE, Nicholas RA, Peek ML, Simon AJ (2000): Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against Mycoplasma mycoides subspecies mycoides small colony type. Veterinary Record 146, 243-246. Go to original source... Go to PubMed...
  4. Bashiruddin JB, Frey J, Konigsson MH, Johansson KE, Hotzel H, Diller R, Santis P, Botelho A, Ayling RD, Nicholas RAJ, Thiaucourt F, Sachse K (2005): Evaluation of PCR systems for the identification and differentiation of Mycoplasma agalactiae and Mycoplasma bovis: a collaborative trial. Veterinary Journal 169, 268-275. Go to original source... Go to PubMed...
  5. Boothe D (1998): The Marck Veterinary Manual. In: Asiello S (eds.): Antibacterial Agents. Merck and Co, Inc, Philadelphia. 1745-1788.
  6. Caswell JL, Archambault M (2008): Mycoplasma bovis pneumonia in cattle. Animal Health Research Reviews 8, 161-186. Go to original source... Go to PubMed...
  7. Clyde WA (1964): Mycoplasma species identification based upon growth inhibition by specific antisera. Journal of Immunological Methods 92, 958-965. Go to original source...
  8. Fox LK, Kirk JH, Britten A (2005): Mycoplasma mastitis: a review of transmission and control. Journal of Veterinary Medicine Series B 52, 153-160. Go to original source... Go to PubMed...
  9. Francoz D, Fortin M, Fecteau G, Messier S (2005): Determination of Mycoplasma bovis susceptibilities against six antimicrobial agents using the E test method. Veterinary Microbiology 105, 57-64. Go to original source... Go to PubMed...
  10. Friis NF (1975): Some recommendations concerning primary isolations of Mycoplasma suipneumoniae and Mycoplasma flocculare. Nord Veterinary Medicine 27, 337-339.
  11. Gabinaitiene A, Siugzdaite J, Zilinskas H (2011): Laboratory diagnosis of Mycoplasma infection in young cattle. Polish Journal of Veterinary Sciences 14, 87-93. Go to original source... Go to PubMed...
  12. Gagea MI, Bateman KG, Van Dreumel T, McEwen BJ, Carman S, Archambault M, Shanahan RA, Caswell JL (2006): Diseases and pathogens associated with mortality in Ontario beef feedlots. Journal of Veterinary Diagnostic Investigation 18, 18-28. Go to original source... Go to PubMed...
  13. Gautier-Bouchardon AV, Reinhardt AK, Kobisch M, Kempf I (2002): In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae. Veterinary Microbiology 88, 47-58. Go to original source... Go to PubMed...
  14. Gerchman I, Levisohn S, Mikula I, Lysnyansky I (2009): In vitro antimicrobial susceptibility of Mycoplasma bovis isolated in Israel from local and imported cattle. Veterinary Microbiology 137, 268-275. Go to original source... Go to PubMed...
  15. Godinho KS, Wolf LG, Sherington J, Rowan TG, Sunderland SJ, Evans NA (2005): Efficacy of tulathromycin in the treatment and prevention of natural outbreaks of bovine respiratory disease in European cattle. Veterinary Therapeutics 6, 122-135. Go to PubMed...
  16. Goll FJR (1994): Identification of Mycoplasmas isolated from domestic animals. In: Whitford HW, Rosenbusch RF, Lauerman LH (eds.): Mycoplasmosis in Animals: Laboratory Diagnosis. Iowa State University Press, Iowa, 15-30.
  17. Hannan PC (2000): Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary Mycoplasma species. International Research Programme on Comparative Mycoplasmology. Veterinary Research 31, 373-395. Go to original source... Go to PubMed...
  18. Hirose K, Kobayashi H, Ito N, Kawasaki Y, Zako M, Kotani K, Ogawa H, Sato H (2003): Isolation of Mycoplasmas from nasal swabs of calves affected with respiratory diseases and antimicrobial susceptibility of their isolates. Journal of Veterinary Medicine B 50, 347-351. Go to original source... Go to PubMed...
  19. Hirose K, Kawasaki Y, Kotani K (2004): Characterization of a point mutation in the parC gene of Mycoplasma bovirhinis associated with fluoroquinolone resistance. Journal of Veterinary Medicine B 51, 169-175. Go to original source... Go to PubMed...
  20. Inamoto T, Takahashi K, Yamamoto K, Nakai Y, Ogimoto K (1994): Antibiotic susceptibility of Mycoplasma hyopneumoniae isolated from swine. Journal of Veterinary Medical Science 56, 393-394. Go to original source... Go to PubMed...
  21. Kaluina V (1998): Avian mycoplasmosis (in Lithuanian). Margi Rastai, Vilnius. 215 pp.
  22. Kilgore WR, Spensley MS, Sun F, Nutsch RG, Rooney KA, Skogerboe TL (2005): Therapeutic efficacy of tulathromycin, a novel triamilide antimicrobial, against bovine respiratory disease in feeder calves. Veterinary Therapeutics 6, 143-153. Go to PubMed...
  23. Kobayashi H, Morozumi T, Munthali G, Mitani K, Ito N, Yamamoto K (1996): Macrolide susceptibility of Mycoplasma hyorhinis isolated from piglets. Antimicrobial Agents and Chemotherapy 40, 1030-1032. Go to original source... Go to PubMed...
  24. Liu J, Fung KF, Chen Z, Zeng Z, Zhang J (2003): Pharmacokinetics of florfenicol in healthy pigs and in pigs experimentally infected with Actinobacillus pleuropneumoniae. Antimicrobial Agents and Chemotherapy 47, 820-823. Go to original source... Go to PubMed...
  25. Maunsell FP, Donovan GA, Risco C, Brown MB (2009): Field evaluation of a Mycoplasma bovis bacterin in young dairy calves. Vaccine 27, 2781-2788. Go to original source... Go to PubMed...
  26. NCCLS (2002). Development of in vitro susceptability testing criteria and quality control parameters for veterinary antimicrobial agents, approved guideline, 22.
  27. Reinhardt AK, Bebear CM, Kobisch M, Kempf I, GautierBouchardon AV (2002): Characterization of mutations in DNA gyrase and topoisomerase IV involved in quinolone resistance of Mycoplasma gallisepticum mutants obtained in vitro. Antimicrobial Agents and Chemotherapy 46, 590-593. Go to original source... Go to PubMed...
  28. Rosenbusch RF, Kinyon JM, Apley M, Funk ND, Smith S, Hoffman LJ (2005): In vitro antimicrobial inhibition profiles of Mycoplasma bovis isolates recovered from various regions of the United States from 2002 to 2003. The Journal of Veterinary Diagnostic Investigation 17, 436-441. Go to original source... Go to PubMed...
  29. Siugzdaite J (2002): Detection of Mycoplasma bovis from Hayflick-agar media by polymerase chain reaction. Zemes Ukio Mokslai 1, 67-70.
  30. Skogerboe LT, Rooney AK, Nutsch RG, Weigel DJ, Gajewski K, Kilgore WR (2006): Comparative efficacy of tulathromycin versus florfenicol and tilmicosin against undifferentiated bovine respiratory disease in feedlot cattle. Veterinary Therapeutics 6, 180-196.
  31. Stipkovits L, Ripley PH, Tenk M, Glavits R, Molnar T, Fodor L (2005): The efficacy of valnemulin (Econor) in the control of disease caused by experimental infection of calves with Mycoplasma bovis. Research in Veterinary Science 78, 207-215. Go to original source... Go to PubMed...
  32. Tenk M (2005): Examination of Mycoplasma bovis infection in cattle. [Doctoral Thesis.] Budapest, 70 pp.
  33. Ter Laak EA, Noordergraaf JH, Dieltjes RP (1992): Prevalance of Mycoplasmas in the respiratory tract of pneumonic calves. Zentralblatt fur Veterinarmedizin Reihe B 39, 553-562. Go to original source... Go to PubMed...
  34. Ter Laak EA, Noordergraaf JH, Verschure MH (1993): Susceptibilities of Mycoplasma bovis, Mycoplasma dispar, and Ureaplasma diversum strains to antimicrobial agents in vitro. Antimicrobial Agents and Chemotherapy 37, 317-321. Go to original source... Go to PubMed...
  35. Thomas A, Ball H, Dizier I, Trolin A, Bell C, Mainil J, Linden A (2002): Isolation of Mycoplasma species from the lower respiratory tract of healthy cattle and cattle with respiratory disease in Belgium. Veterinary Record 151, 472-476. Go to original source... Go to PubMed...
  36. Thomas A, Nicolas C, Dizier I, Mainil J, Linden A (2003): Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium. Veterinary Record 153, 428-431. Go to original source... Go to PubMed...
  37. Timenetsky J, Santos LM, Buzinhani M, Mettifogo E (2006): Detection of multiple Mycoplasma infection in cell cultures by PCR. Brazilian Journal of Medical and Biological Research 39, 907-914. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.